Liquiritin ameliorates metabolic and endocrine alterations in a mouse model of polycystic ovary syndrome

Liquiritin ameliorates metabolic and endocrine alterations in a mouse model of polycystic ovary syndrome

Abstract. Objective:. Altered bile acid transformation induces low-grade chronic inflammation and may play an important role in the pathophysiology of polycystic ovary syndrome (PCOS). Liquiritincan regulate bile acid metabolism and anti-inflammatory properties; however, limited information is avail...

Full description

Bibliographic Details
Main Authors: Zhi Li, Yan Liu, Hai-Ou Liu, Zhi-Yong Wu, Cong-Jian Xu, Fei-Fei Zhang, Yong-Qing Zhu
Format: Article
Language:English
Published: Wolters Kluwer Health/LWW 2022-06-01
Series:Reproductive and Developmental Medicine
Online Access:http://journals.lww.com/10.1097/RD9.0000000000000025

Internet

http://journals.lww.com/10.1097/RD9.0000000000000025

Similar Items